Skip to content

Feasibility study of different doses of oxycodone for ophthalmologic surgery in adult patients

Feasibility study of different doses of oxycodone for ophthalmologic surgery in adult patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16007927
Enrollment
Unknown
Registered
2016-02-15
Start date
2016-02-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

application of oxycodone in patients undergoing ophthalmic surgery

Interventions

oxycodone group1:oxycodone 0.1mg/kg
oxycodone group2:oxycodone 0.2mg/kg
fentanyl group :fentanyl 2ug/kg

Sponsors

The Eye, Ear, Nose and Throat Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Under general anesthesia for ophthalmic surgery, older than 18 and less than 85 years of age, male or female, ASA grade I or II, no chronic pain, no analgesic, sedative and antidepressants for a long time, without a history of alcohol abuse, 24 h before surgery is not used sedative, analgesic and antidepressants

Exclusion criteria

Exclusion criteria: Younger than 18 years old or over 85 years old, ASA grade greater than II, long-term chronic pain, long-term use of analgesics, sedatives or antidepressants, the presence of alcohol abuse, have recently taken or are taking sedatives, analgesics, antidepressants

Design outcomes

Primary

MeasureTime frame
time of recover spontaneous respiration;time of extubation;Head up for 5 seconds;time of leave PACU;NRS pain scores;Ramsay sedation score;OAA/S sedation rating;blood pressure;heart rate;saturation of pulse oxygen;Bispectral Index;Sevoflurane usage;Analgesic dosage;

Secondary

MeasureTime frame
Other adverse reactions;Vasoactive drug dosage;

Countries

China

Contacts

Public ContactTAN FANG
tanfang1977@hotmail.com+86 13611716000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026